Detalhe da pesquisa
1.
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
Blood Adv
; 7(11): 2459-2462, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622349